Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study
Clinical trial NCT01018186 · COMPLETED
Trial details
- NCT number
- NCT01018186
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-19
- Primary completion
- 2011-05-01
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.